Centre Hospitalier de l'Université de Montréal ( Site 0300)

Montreal, Quebec H2X 3E4

0 studies enrolling now · 1 studies all time

What they study most

High-grade Serous Ovarian Carcinoma, Ovarian Carcinoma

Studies at this site

• Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002) — Completed